Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-15-060445
Filing Date
2015-10-22
Accepted
2015-10-22 16:36:46
Documents
2
Period of Report
2015-10-21

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v422665_3.html 3  
1 OWNERSHIP DOCUMENT v422665_3.xml 3 7381
2 EXHIBIT 24 v422665_ex24.htm EX-24 8789
  Complete submission text file 0001144204-15-060445.txt   17678
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Issuer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TONIX PHARMACEUTICALS HOLDING CORP 509 MADISON AVE., SUITE 306 NEW YORK NY 10022
Business Address
MORRIS JESSICA EDGAR (Reporting) CIK: 0001656531 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36019 | Film No.: 151170582